Lupin receives FDA OK for generic Esbriet
Generic Esbriet is an anti-fibrotic used to treat idiopathic pulmonary fibrosis.
Lupin has received approval from the Food and Drug Administration for Pirfenidone tablets, 267 mg and 801 mg, which is a generic of Hoffmann La Roche’s Esbriet.
Generic Esbriet is an anti-fibrotic used to treat idiopathic pulmonary fibrosis.
[Read more: Lupin receives FDA OK for generic Banzel]
The product will be manufactured at Lupin’s Pithampur facility in India.
Pirfenidone tablets (Esbriet) had a market value of roughly $218 million, per IQVIA June 2023 data.
[Read more: FDA approves 3 Lupin generics]